Genetics and Life Insurance: A Comparative Analysis
dc.contributor.author | Lemmens, Trudo | |
dc.contributor.author | Joly, Yann | |
dc.contributor.author | Knoppers, Bartha Maria | |
dc.date.accessioned | 2008-04-21T20:29:56Z | |
dc.date.available | 2008-04-21T20:29:56Z | |
dc.date.issued | 2004 | |
dc.identifier.uri | http://hdl.handle.net/1866/2275 | |
dc.format.extent | 141284 bytes | |
dc.format.mimetype | application/pdf | |
dc.publisher | GenEdit | en |
dc.title | Genetics and Life Insurance: A Comparative Analysis | en |
dc.type | Article | en |
dc.contributor.affiliation | Université de Montréal. Faculté de droit | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de droit. Centre de recherche en droit public | fr |
dcterms.abstract | The debate surrounding the role of life insurance, the necessity of risk rating, and the notion of “acceptable discrimination” has raised questions about the larger social role of insurance. Recent developments in the field of genetics, allowing insurers to make use of genetic testing technology as a new underwriting tool, have reinvigorated this debate. This article presents a comparative study of positions taken in countries on issues in genetics and life insurance. We will analyze the 43 selected countries and comment on their potential for ensuring a more equitable access for life insurance applicants. | en |
dcterms.description | [À l'origine dans / Was originally part of : CRDP - Droit, biotechnologie et rapport au milieu] | fr |
dcterms.language | eng | en |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | |
oaire.citationTitle | GenEdit | |
oaire.citationVolume | II | |
oaire.citationIssue | 2 | |
oaire.citationStartPage | 1 | |
oaire.citationEndPage | 14 |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.